Issue 45, 2022

Synthesis of pyrrothiamine, a novel thiamine analogue, and evaluation of derivatives as potent and selective inhibitors of pyruvate dehydrogenase

Abstract

Inhibition of thiamine pyrophosphate (TPP)-dependent enzymes with thiamine/TPP analogues that have the central thiazolium ring replaced with other rings is well established, but a limited number of central rings have been reported. We report a novel analogue, pyrrothiamine, with a central pyrrole ring. We further develop pyrrothiamine derivatives as potent and selective inhibitors of pyruvate dehydrogenase, which might have anti-cancer potential.

Graphical abstract: Synthesis of pyrrothiamine, a novel thiamine analogue, and evaluation of derivatives as potent and selective inhibitors of pyruvate dehydrogenase

Supplementary files

Article information

Article type
Communication
Submitted
05 Oct 2022
Accepted
28 Oct 2022
First published
31 Oct 2022
This article is Open Access
Creative Commons BY license

Org. Biomol. Chem., 2022,20, 8855-8858

Synthesis of pyrrothiamine, a novel thiamine analogue, and evaluation of derivatives as potent and selective inhibitors of pyruvate dehydrogenase

A. H. Y. Chan, T. C. S. Ho, K. Agyei-Owusu and F. J. Leeper, Org. Biomol. Chem., 2022, 20, 8855 DOI: 10.1039/D2OB01819E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements